In vivo clinical studies have been done on new-born infants (0-8 weeks) with orally administered bifidobacteria and lactobacilli at daily dosage of 9 Billion bacteria and on 100 children aged from 6 to 60 months with a mix of B. infantis and L. acidophilus at a dose of 6 Billion bacteria per day.  Both studies concluded that oral bacterial therapy were effective in low age infants suffering from diarrhoea and could safely be administered without any side effects.

Stay up-to-date with Udo's Choice

Be the first to hear about our new products, expert wellbeing advice, recipes, competitions and offers.

Sign up to our emails for the latest stories and offers